Featured Research

from universities, journals, and other organizations

Women prescribed hormone therapy should use caution when taking apigenin supplement

Date:
November 20, 2013
Source:
University of Missouri-Columbia
Summary:
In 2011, studies conducted found that a natural compound called apigenin, which is found in celery, parsley, and apples, could reduce the incidence of tumor growth in women receiving hormone replacement therapy. Now, based on subsequent studies, they are recommending that women not ingest pure apigenin as a supplement.

Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, are often prescribed to reduce the effects of hot flashes and other menopausal symptoms in women. Research and clinical trials on hormone replacement therapies have indicated a higher incidence of tumors, especially breast cancer, in post-menopausal women who take synthetic hormones; therefore, doctors have become more reluctant to prescribe the treatment. In 2011, studies conducted by University of Missouri researchers found that a natural compound called apigenin, which is found in celery, parsley, and apples, could reduce the incidence of tumor growth in women receiving hormone replacement therapy. Now, based on subsequent studies conducted by MU researchers, they are recommending that women not ingest pure apigenin as a supplement.

A new study shows that when the supplement apigenin is ingested in a diet at the same concentration as subjects received during IV injections in previous studies -- the benefits were reversed leading to a higher incidence of cancerous tumors in subjects receiving progestin.

"Typically, hormone replacement therapies improve the lives of menopausal women and achieve very good results," said Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center. "However, research has proven that in women receiving therapies that involve a combination of the natural component estrogen and the synthetic progestin, a higher incidence of breast cancer tumors can occur."

Hyder explains that many women normally have benign lesions in breast tissue. These lesions don't typically form tumors until they receive the "trigger" that attracts blood vessels to cells essentially feeding the lesions causing them to form and expand -- in this case, progestin is the trigger. Hyder's previous research focused on identifying natural supplements containing compounds that lessen the likelihood of tumor development and growth.

During the study, laboratory rats were divided into four groups. Two groups were placed on a controlled diet; the other two were given apigenin through a diet supplemented with apigenin. Researchers found that the mice that ingested apigenin through their diets were found to have a higher incidence of tumor growth.

"We know that apigenin is effective when injected directly into the bloodstream, so intravenous supplements may still be a possibility," Hyder said. "However, the mice that ingested apigenin began metabolizing it -- which seemed to aggravate the situation causing very aggressive growth of mammary tumors."

"Women should continue consuming a healthy diet," Hyder said. "Fruits and vegetables most likely contain other protective compounds, and there is no data to suggest that these items are harmful. However, we do not recommend that women who are on hormone replacement therapy with a progestin component ingest pure apigenin as a supplement until further research proves otherwise. Until we know how apigenin is metabolized and interact with progestin effects, we cannot recommend that women supplement their hormone replacement therapy with this compound."

Researchers involved with the study included Benford Mafuvadze, post-doctoral fellow at Dalton Cardiovascular Research Center; Matthew Cook, pre-doctoral fellow in Biomedical Sciences; Cynthia Besch-Williford, professor of veterinary pathobiology; and Xu Zhang, visiting researcher at the Dalton Cardiovascular Research Center.

The research was recently published online in the journal Nutrition and Cancer.


Story Source:

The above story is based on materials provided by University of Missouri-Columbia. Note: Materials may be edited for content and length.


Journal Reference:

  1. Benford Mafuvadze, Matthew Cook, Zhang Xu, Cynthia L. Besch-Williford, Salman M. Hyder. Effects of Dietary Apigenin on Tumor Latency, Incidence and Multiplicity in a Medroxyprogesterone Acetate- Accelerated 7,12-Dimethylbenz(a)anthracene- Induced Breast Cancer Model. Nutrition and Cancer, 2013; 65 (8): 1184 DOI: 10.1080/01635581.2013.833637

Cite This Page:

University of Missouri-Columbia. "Women prescribed hormone therapy should use caution when taking apigenin supplement." ScienceDaily. ScienceDaily, 20 November 2013. <www.sciencedaily.com/releases/2013/11/131120155213.htm>.
University of Missouri-Columbia. (2013, November 20). Women prescribed hormone therapy should use caution when taking apigenin supplement. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2013/11/131120155213.htm
University of Missouri-Columbia. "Women prescribed hormone therapy should use caution when taking apigenin supplement." ScienceDaily. www.sciencedaily.com/releases/2013/11/131120155213.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins